Angiotensin II as a cardiovascular risk factor

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Cardiac Pathophysiology

Background:

• Elevated renin-angiotensin system (RAS) activity is a recognized cardiovascular risk factor.
• Angiotensin exerts effects both systemically and locally within cardiac structures.
• RAS activation contributes to adverse cardiac remodeling and dysfunction.

Purpose of the Study:

• To review the mechanisms by which RAS activation damages the heart.
• To highlight the role of RAS in cardiovascular risk.
• To discuss the link between RAS and myocardial injury.

Main Methods:

• Literature review of studies on renin-angiotensin system and cardiac damage.
• Analysis of hemodynamic and humoral consequences of RAS activation.
• Examination of molecular and cellular effects on the myocardium.

Main Results:

• RAS activation leads to myocardial ischemia, left-ventricular hypertrophy, and arrhythmias.
• It alters coagulation-fibrinolysis balance, increases oxidative stress, and promotes inflammation.
• Both mechanical and neurohumoral effects contribute to cardiac damage.

Conclusions:

• Inappropriately high RAS activity is a modifiable factor contributing to heart disease.
• RAS activation initiates multiple pathways leading to myocardial injury.
• Understanding these mechanisms is crucial for cardiovascular risk management.